NCT01827605 2023-12-14
A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)
Fondazione Italiana Linfomi - ETS
Phase 3 Unknown
Clinical Trials
8 trialsNCT01811368 2022-11-30
Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
University of California, Davis
Phase 2 Unknown
NCT00397800 2012-08-28
Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma
Technical University of Munich
Phase 1/2 Unknown
NCT00772655 2012-08-02
Zevalin® First Line in Follicular Lymphoma
Charite University, Berlin, Germany
Phase 2 Unknown
NCT00463463 2012-07-12
Zevalin
Soroka University Medical Center
Phase 3 Unknown
NCT00807196 2008-12-11
Zevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin Lymphoma
Maisonneuve-Rosemont Hospital
Phase 1/2 Unknown
NCT00722930 2008-07-28
GOTEL-FL1LC
Grupo Oncológico para el Tratamiento y el Estudio de los Linfomas
Phase 2 Unknown
NCT00438581 2007-02-27
Zevalin
McGill University
Phase 2 Unknown